Chyloperitoneum, chylothorax and lower extremity lymphedema in woman with sporadic lymphangioleiomyomatosis successfully treated with sirolimus: a case report.
Lymphangioleiomyomatosis (LAM) is a rare disease characterized by diffuse thin-walled cysts throughout the lungs on computed tomography and diffuse proliferation of abnormal smooth muscle-like cells (LAM cells) on lung biopsy. LAM affects women almost exclusively, predominantly in their reproductive age. The most typical presenting symptoms include dyspnea, spontaneous pneumothorax, cough and chylothorax. Abdominal findings represent less common initial manifestations of the disease and may pose diagnostic difficulties. The treatment of LAM has not been fully established. Recent studies report effectiveness of sirolimus in LAM patients. We report the case of a 45-year-old woman with sporadic LAM, successfully treated with sirolimus, in whom the first manifestation of the disease was chyloperitoneum and after three and nine years, respectively, lymphedema of the left lower extremity and right sided chylothorax occurred.
Department of Internal Medicine, Wroclaw Medical University, Wroclaw, Poland.
A
A
Chachaj
K
K
Drozdz
M
M
Chabowski
P
P
Dziegiel
I
I
Grzegorek
A
A
Wojnar
P
P
Jazwiec
A
A
Szuba
D002916:Chylothorax / Q000175:diagnosis / Q000188:drug therapy*; D002915:Chylous Ascites / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007866:Leg; D018192:Lymphangioleiomyomatosis / Q000188:drug therapy*; D008209:Lymphedema / Q000175:diagnosis / Q000188:drug therapy*; D008875:Middle Aged; D011379:Prognosis; D020123:Sirolimus / Q000627:therapeutic use*; D014057:Tomography, X-Ray Computed
D007166:Immunosuppressive Agents; D020123:Sirolimus